Skip to main content
Completed Clinical Trials

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

By April 24, 2017No Comments

Condition

Mesothelioma

Estimated Enrollment: 24

Age Group: 18 Years to 100 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Treatment

Study ID Numbers: 080026|08-C-0026

Study First Received: September 30, 2011

Last Updated: April 20, 2017

Estimated Primary Completion Date: January 31, 2014

 

Primary Outcome Measures:

Safety and MTD|Best overall response

Sponsors and Collaborators:

National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)

Website Link: https://ClinicalTrials.gov/show/NCT01445392

Leave a Reply